| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.74 | 0.006 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |